{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL999&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=HL999&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL999&_metadata=all&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=HL999&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL999&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL999&answer.answeringMemberPrinted=Earl+Howe&max-answer.questionFirstAnswered.=2015-07-08T15%3A34%3A22.203Z", "items" : [{"_about" : "http://data.parliament.uk/resources/386890", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/386890/answer", "answerText" : {"_value" : "

The UK has, and continues to face, a broad range of complex threats both at home and abroad.<\/p>

The table below shows the proportion of gross domestic product that the UK has spent on defence each year since 1985. This data is published annually by NATO as part of its Defence Expenditure publications.<\/p>

<\/p>

Year<\/strong><\/p><\/td>

Percentage of GDP spent on Defence<\/strong><\/p><\/td><\/tr>

1985<\/p><\/td>

5.2<\/p><\/td><\/tr>

1986<\/p><\/td>

4.9<\/p><\/td><\/tr>

1987<\/p><\/td>

4.6<\/p><\/td><\/tr>

1988<\/p><\/td>

3.2<\/p><\/td><\/tr>

1989<\/p><\/td>

4.1<\/p><\/td><\/tr>

1990<\/p><\/td>

4.1<\/p><\/td><\/tr>

1991<\/p><\/td>

4.3<\/p><\/td><\/tr>

1992<\/p><\/td>

3.8<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

<\/p>

1993<\/p><\/td>

3.6<\/p><\/td><\/tr>

1994<\/p><\/td>

3.4<\/p><\/td><\/tr>

1995<\/p><\/td>

3.1<\/p><\/td><\/tr>

1996<\/p><\/td>

3<\/p><\/td><\/tr>

1997<\/p><\/td>

2.7<\/p><\/td><\/tr>

1998<\/p><\/td>

2.6<\/p><\/td><\/tr>

1999<\/p><\/td>

2.5<\/p><\/td><\/tr>

2000<\/p><\/td>

2.5<\/p><\/td><\/tr>

2001<\/p><\/td>

2.5<\/p><\/td><\/tr>

2002<\/p><\/td>

2.4<\/p><\/td><\/tr>

2003<\/p><\/td>

2.4<\/p><\/td><\/tr>

2004<\/p><\/td>

2.2<\/p><\/td><\/tr>

2005<\/p><\/td>

2.5<\/p><\/td><\/tr>

2006<\/p><\/td>

2.4<\/p><\/td><\/tr>

2007<\/p><\/td>

2.5<\/p><\/td><\/tr>

2008<\/p><\/td>

2.6<\/p><\/td><\/tr>

2009<\/p><\/td>

2.6<\/p><\/td><\/tr>

2010<\/p><\/td>

2.6<\/p><\/td><\/tr>

2011<\/p><\/td>

2.6<\/p><\/td><\/tr>

2012<\/p><\/td>

2.2<\/p><\/td><\/tr>

2013<\/p><\/td>

2.3<\/p><\/td><\/tr>

2014<\/p><\/td>

2.2<\/p><\/td><\/tr>

2015<\/p><\/td>

2.1<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2015-07-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-07-08T15:34:22.203Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2015-07-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Defence"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government over what periods in the last 30 years there has been a threat to the existence of the United Kingdom; and what was the average percentage of gross domestic product spent on defence in each of those years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3834", "label" : {"_value" : "Biography information for Lord West of Spithead"} } , "tablingMemberPrinted" : [{"_value" : "Lord West of Spithead"} ], "uin" : "HL999"} , {"_about" : "http://data.parliament.uk/resources/77265", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77265/answer", "answerText" : {"_value" : "

The former Health Protection Agency's Lyme Borreliosis Unit (HPA LBU) was accredited by Clinical Pathology Accreditation who had access to, and was able to review, all the standard operating procedures of the unit.<\/p>

<\/p>

The Trinity Biotech Lyme Western Blot is a qualitative in vitro assay for the detection of Immunoglobulin (IgG or IgM) antibodies in human samples against specific antigens/proteins of Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi<\/em>. The Trinity Biotech Lyme Western Blot is intended as a confirmatory assay for use in testing human samples which have been previously found to be positive or equivocal using an Enzyme Immunoassay and Immunofluroescent Assay or other appropriate screening method. Positive second-tier results are supportive evidence of infection with B. burgdorferi<\/em>. The diagnosis of Lyme disease should be made based on history and symptoms (such as erythema migrans), and other laboratory data, in addition to the presence of antibodies to B. burgdorferi<\/em>. The Trinity Biotech blot has been in use since 2007 by the former HPA\u2019s LBU for testing cerebrospinal fluid (CSF) and proved very reliable. This technique has also been in use widely across Europe during this period as a diagnostic test using CSF as a sample to support the diagnosis of neuroborreliosis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2014-07-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-07-24T12:32:59.6647091Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lyme Disease"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government whether, in December 2011, the Clinical Pathology Accreditation Service was made aware of modifications by the Health Protection Agency\u2019s Lyme Borreliosis Unit to the Trinity Biotech immunoblot kit to be used for testing human cerebrospinal fluid.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"} } , "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"} ], "uin" : "HL999"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }